This book offers a comprehensive exploration of cognitive disabilities, particularly associated with Alzheimer's disease (AD), primarily focusing on understanding, diagnosing, managing, and advancing the treatment of these impairments. The scope of this book extends beyond existing strategies by offering research-focused content, including diagnostic tools, emerging treatment modalities, and the latest developments in nanotechnology and artificial intelligence (AI) for the management of AD-associated cognitive disabilities. The book’s unique viewpoint on the diagnosis and therapeutic management of cognitive disabilities as the primary focus of Alzheimer's pathology makes it an indispensable resource for neuroscientists, cognitive researchers, and medical professionals. By connecting clinical insights with current research, the book provides readers with a deeper understanding of the disease’s mechanisms, which can be applied for related clinical or research purposes.

This book offers a comprehensive exploration of cognitive disabilities, particularly associated with Alzheimer's disease (AD), primarily focusing on understanding, diagnosing, managing, and advancing the treatment of these impairments. The scope of this book extends beyond existing strategies by offering research-focused content, including diagnostic tools, emerging treatment modalities, and the latest developments in nanotechnology and artificial intelligence (AI) for the management of AD-associated cognitive disabilities. The book’s unique viewpoint on the diagnosis and therapeutic management of cognitive disabilities as the primary focus of Alzheimer's pathology makes it an indispensable resource for neuroscientists, cognitive researchers, and medical professionals. By connecting clinical insights with current research, the book provides readers with a deeper understanding of the disease’s mechanisms, which can be applied for related clinical or research purposes.

This book offers a comprehensive exploration of cognitive disabilities, particularly associated with Alzheimer's disease (AD), primarily focusing on understanding, diagnosing, managing, and advancing the treatment of these impairments. The scope of this book extends beyond existing strategies by offering research-focused content, including diagnostic tools, emerging treatment modalities, and the latest developments in nanotechnology and artificial intelligence (AI) for the management of AD-associated cognitive disabilities. The book’s unique viewpoint on the diagnosis and therapeutic management of cognitive disabilities as the primary focus of Alzheimer's pathology makes it an indispensable resource for neuroscientists, cognitive researchers, and medical professionals. By connecting clinical insights with current research, the book provides readers with a deeper understanding of the disease’s mechanisms, which can be applied for related clinical or research purposes.